- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:45 | Globus Medical beats Street in Q4, stock dips as analysts question Nevro buy | ||
| 17:15 | iRhythm stock rises on Q4 results, on-target FDA remediation efforts | ||
| 16:45 | UroMems reports positive outcomes in first-ever female-only study of smart implant for incontinence | ||
| 15:45 | Philips, Mass General Brigham ink AI care collab | ||
| Do | Baxter stock rises on Street-beating, better-than-expected Q4 | ||
| Do | Outset Medical stock rises on Street-beating Q4, 2025 guidance | ||
| Do | Valencia Technologies raises $35M for coin-sized neuromod device, picks new CEO | ||
| Do | Data backs Lungpacer Medical's diaphragm neurostim | ||
| Mi | Medtronic launches spinal system for deformity procedures | ||
| Mi | First patient enrolled in IDE study of Conformal Medical's next-gen LAAO device | ||
| Mi | Biotronik, Egg Medical collaborate to protect healthcare workers from radiation | ||
| Mi | VitalConnect raises $100M for biosensor tech for cardiac monitoring | ||
| Mi | Lifeward CEO plans to retire | ||
| Mi | Stryker completes acquisition of Inari Medical | ||
| Mi | Accelus names new VP of U.S. sales | ||
| Mi | CMR Surgical reports more than 30,000 patients treated with Versius surgical robot | ||
| Mi | Philips stock sinks before hours on Q4 China performance, finalizes $1.1B Respironics settlement | ||
| Di | Vicarious Surgical COO plans to retire | ||
| Di | Salvia BioElectronics reports first migraine therapy implant in The Netherlands | ||
| Di | Kestra Medical picks former Axonics exec as new CCO | ||
| Di | E2 raises $42M Series B to advance clot removal tech | ||
| Di | BCI maker Subsense emerges from stealth mode with $17M in seed funding | ||
| Di | FDA medtech regulators reportedly in among latest Trump layoffs | ||
| Di | Medtronic slightly misses on revenue in Q3 | ||
| Di | Level Zero Health raises $6.9M for remote monitoring sensors |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
